Effects of chronic renal failure on the pharmacokinetics of ruboxistaurin and its active metabolite 338522
Clinical Pharmacokinetics
Saved in:
Main Authors: | Wise, S., Yuen, E., Chan, C., Yeo, K.P., Teng, L., Lau, T., Voelker, J. |
---|---|
Other Authors: | STATISTICS & APPLIED PROBABILITY |
Format: | Article |
Published: |
2014
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/105105 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Effects of chronic renal failure on the pharmacokinetics of ruboxistaurin and its active metabolite 338522
by: Wise, S., et al.
Published: (2011) -
Pharmacokinetics of ruboxistaurin are significantly altered by rifampicin-mediated CYP3A4 induction
by: Yeo, K.P., et al.
Published: (2014) -
Pharmacokinetics of quinine in patients with chronic renal failure
by: P. Rimchala, et al.
Published: (2018) -
Clinical pharmacokinetics of alamifovir and its metabolites
by: Chan, C., et al.
Published: (2014) -
Pharmacokinetics of intravenous vancomycin in patients with end-stage renal failure
by: Tan, C.C., et al.
Published: (2012)